These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

949 related items for PubMed ID: 24479248

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The US approach to biosimilars: the long-awaited FDA approval pathway.
    Calvo B, Zuñiga L.
    BioDrugs; 2012 Dec 01; 26(6):357-61. PubMed ID: 23030677
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Controversies in Establishing Biosimilarity: Extrapolation of Indications and Global Labeling Practices.
    Ebbers HC, Chamberlain P.
    BioDrugs; 2016 Feb 01; 30(1):1-8. PubMed ID: 26758077
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biosimilars: the paradox of sharing the same pharmacological action without full chemical identity.
    Pani L, Montilla S, Pimpinella G, Bertini Malgarini R.
    Expert Opin Biol Ther; 2013 Oct 01; 13(10):1343-6. PubMed ID: 23805906
    [Abstract] [Full Text] [Related]

  • 7. Biosimilars: The US Regulatory Framework.
    Christl LA, Woodcock J, Kozlowski S.
    Annu Rev Med; 2017 Jan 14; 68():243-254. PubMed ID: 27813877
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The story of biosimilars--chance or threat?].
    Woroń J, Kocić I.
    Pol Merkur Lekarski; 2014 Nov 14; 37(221):311-5. PubMed ID: 25546996
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A Systematic Review of U.S. Biosimilar Approvals: What Evidence Does the FDA Require and How Are Manufacturers Responding?
    Hung A, Vu Q, Mostovoy L.
    J Manag Care Spec Pharm; 2017 Dec 14; 23(12):1234-1244. PubMed ID: 29172975
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The constitutional protection of trade secrets and patents under the Biologics Price Competition and Innovation Act of 2009.
    Epstein RA.
    Food Drug Law J; 2011 Dec 14; 66(3):285-328. PubMed ID: 24505851
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Biosimilar safety factors in clinical practice.
    Reinisch W, Smolen J.
    Semin Arthritis Rheum; 2015 Jun 14; 44(6 Suppl):S9-15. PubMed ID: 26058551
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.